ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 13 of 29

14 Treatment Table 4. Medication Formulations Brand Name Generic Name Treatment of Strengths / Formulations Generic Methadone Opioid withdrawal and OUD Tablet: 5mg, 10mg Dispersible tablet: 40mg Oral solution: 5mg/5mL, 10mg/5mL Oral concentrate solution: 10mg/mL Generic Buprenorphine (monoproduct) Sublingual tablet: 2mg, 8mg Generic Buprenorphine and naloxone Sublingual tablet (bup/nal): 2mg/0.5mg, 8mg/2mg Zubsolv Sublingual tablet (bup/nal): 0.7mg/0.18mg, 1.4mg/0.36mg, 2.9mg/0.71mg, 5.7mg/1.4mg, 8.6mg/2.1mg, 11.4mg/2.9mg Bunavail Buccal film (bup/nal): 2.1mg/0.3mg, 4.2mg/0.7mg, 6.3mg/1mg Suboxone Sublingual film (or bucal) (bup/nal): 2mg/0.5mg, 4mg/1mg, 8mg/2mg, 12mg/3mg Cassipa Sublingual film (bup/nal): 16mg/4mg

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update